Kobe Bryant was one of the greatest professional basketball players of all time.
He scored 33,643 points during his 20-year career playing for the Los Angeles Lakers…
He had 7,047 rebounds and 6,306 assists over that time…
And he won five NBA championships.
Of course, he was paid handsomely for his incredible talents and notched a career earnings total of $323,312,307.
That is an enormous amount of money.
But guess what?
He made even more off the court.
In 2014, during his 19th season with the Lakers, Bryant invested $6 million into the sports drink company, Body Armor, in exchange for 10% of the company.
Sounds kind of like a boring pitch you might hear on Shark Tank…
But just seven years later, that stake is now worth an estimated $400 million.
Kobe made more on a single investment than he did from his 20-year career in the NBA.
In 2016, Kobe then started a venture capital firm called Bryant Stibel with his business partner Jeff Stibel, an entrepreneur who previously served as chief executive at several different companies.
Today, Bryant Stibel has more than $2 billion in assets.
According to its website, is focused on providing “strategy, capital and operational support to businesses with a focus across technology, media and data.”
It has made sizeable investments in Epic Games — the maker of the popular Fortnite video game…
The Players’ Tribune — a sports media platform founded by former major league baseball player Derek Jeter…
And The Honest Company (HNST), a consumer goods company founded by actress Jessica Alba that later went public.
It’s also invested in LegalZoom.com, Inc. (LZ), TeamViewer and even Alibaba (BABA).
Trade Like Kobe
It’s clear Kobe was following in the footsteps of some great investors before his untimely passing in early 2020.
Regular readers may remember that, back on Nov. 5, I told you Tesla, Inc. (TSLA) CEO Elon Musk’s “unprecedented increase in wealth came from a highly concentrated position in a market-leading growth stock.”
Well, that’s very similar to what Kobe did with his Body Armor investment, which netted him a 6,500% return in only seven years.
And his venture capital firm shows that he knew the power of investing in early-stage companies… something we try to do fairly often here at Stock Surge Daily.
I’m not just talking about small, early-stage biotechnology stocks either…
Remember legendary trader Richard Wyckoff from our Sept. 21 issue,
He developed his Buy-and-Sell Stock Cycle, which helps us find stocks that are trading in either Stage 1 (Consolidation) or Stage 2 (Accumulation).
And this is how regular investors like us can try to mimic what a private equity or venture capital firm like Bryant Stibel does.
Invest Like the Best
We want to buy stocks when the big players and institutions are getting involved, and we hold them as they rise in value during the accumulation stage.
But as we’ve talked about recently, having a plan for knowing when to sell a stock is also crucial.
Lastly, if you’re unsure of how to best take advantage of our weekly trades…
Be sure to check out my recent article, How to Follow My Weekly Trades.
In it, we walk step by step through how to know where I’m buying so that you can follow along and potentially earn some venture-capital-like returns as well.
Embrace the surge,
Editor, Stock Surge Daily